A detailed history of Aviva PLC transactions in Amgen Inc stock. As of the latest transaction made, Aviva PLC holds 333,580 shares of AMGN stock, worth $87.9 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
333,580
Previous 325,771 2.4%
Holding current value
$87.9 Million
Previous $102 Million 5.6%
% of portfolio
0.29%
Previous 0.3%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $2.42 Million - $2.63 Million
7,809 Added 2.4%
333,580 $107 Million
Q2 2024

Aug 02, 2024

BUY
$262.75 - $319.31 $18.5 Million - $22.5 Million
70,311 Added 27.52%
325,771 $102 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $3.09 Million - $3.73 Million
11,503 Added 4.72%
255,460 $72.6 Million
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $10.1 Million - $11.4 Million
39,486 Added 19.31%
243,957 $70.3 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $1.52 Million - $1.89 Million
6,960 Added 3.52%
204,471 $55 Million
Q2 2023

Aug 10, 2023

BUY
$214.27 - $253.37 $9.87 Million - $11.7 Million
46,084 Added 30.43%
197,511 $43.9 Million
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $7.21 Million - $8.78 Million
-31,917 Reduced 17.41%
151,427 $36.6 Million
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $5.8 Million - $7.38 Million
25,344 Added 16.04%
183,344 $48.2 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $7.92 Million - $8.93 Million
-35,273 Reduced 18.25%
158,000 $35.6 Million
Q2 2022

Aug 04, 2022

BUY
$230.71 - $256.74 $3.51 Million - $3.9 Million
15,208 Added 8.54%
193,273 $47 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $1.32 Million - $1.46 Million
-6,026 Reduced 3.27%
178,065 $43.1 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $1.71 Million - $1.96 Million
8,596 Added 4.9%
184,091 $41.4 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $4.97 Million - $5.82 Million
-23,391 Reduced 11.76%
175,495 $37.3 Million
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $2.4 Million - $2.67 Million
-10,296 Reduced 4.92%
198,886 $48.5 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $332,421 - $387,382
-1,498 Reduced 0.71%
209,182 $52 Million
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $966,136 - $1.15 Million
4,465 Added 2.17%
210,680 $48.4 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $1.87 Million - $2.08 Million
-7,968 Reduced 3.72%
206,215 $52.4 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $1.69 Million - $2.07 Million
-8,525 Reduced 3.83%
214,183 $50.5 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $1.88 Million - $2.49 Million
10,321 Added 4.86%
222,708 $45.2 Million
Q4 2019

Feb 10, 2020

SELL
$189.21 - $243.2 $894,017 - $1.15 Million
-4,725 Reduced 2.18%
212,387 $51.2 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $1.59 Million - $1.91 Million
-9,149 Reduced 4.04%
217,112 $42 Million
Q2 2019

Jul 30, 2019

SELL
$166.7 - $195.41 $9.69 Million - $11.4 Million
-58,110 Reduced 20.43%
226,261 $41.7 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $9.84 Million - $11.1 Million
-54,389 Reduced 16.06%
284,371 $54 Million
Q4 2018

Feb 12, 2019

SELL
$178.4 - $208.25 $13.9 Million - $16.2 Million
-77,808 Reduced 18.68%
338,760 $65.9 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $4 Million - $4.51 Million
-21,567 Reduced 4.92%
416,568 $86.4 Million
Q2 2018

Aug 01, 2018

SELL
$166.05 - $186.51 $5.96 Million - $6.69 Million
-35,863 Reduced 7.57%
438,135 $80.9 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $11.6 Million - $13.5 Million
-68,255 Reduced 12.59%
473,998 $80.8 Million
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $10.6 Million - $11.8 Million
-62,608 Reduced 10.35%
542,253 $94.3 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $118,943 - $135,801
711 Added 0.12%
604,861 $113 Million
Q2 2017

Aug 07, 2017

BUY
N/A
604,150
604,150 $104 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.